Rong Ding

2.1k total citations
81 papers, 1.3k citations indexed

About

Rong Ding is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Rong Ding has authored 81 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Rong Ding's work include Microbial Natural Products and Biosynthesis (7 papers), Natural product bioactivities and synthesis (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). Rong Ding is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Natural product bioactivities and synthesis (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). Rong Ding collaborates with scholars based in China, United States and Hong Kong. Rong Ding's co-authors include Dawei Ye, Haifeng Chen, Ting Lin, Hao Gao, Guanghui Wang, Zhi Li, Wei Wu, Hua‐An Wen, Jiege Huo and Lingchang Li and has published in prestigious journals such as Angewandte Chemie International Edition, The EMBO Journal and Molecular Cell.

In The Last Decade

Rong Ding

79 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong Ding China 21 472 228 193 128 110 81 1.3k
Kamil Biringer Slovakia 23 517 1.1× 157 0.7× 130 0.7× 254 2.0× 120 1.1× 69 1.4k
Hae Dong Woo South Korea 22 405 0.9× 172 0.8× 91 0.5× 138 1.1× 93 0.8× 48 1.4k
Min Su China 22 703 1.5× 187 0.8× 94 0.5× 241 1.9× 95 0.9× 63 1.5k
Ryo Sato Japan 18 491 1.0× 318 1.4× 86 0.4× 132 1.0× 112 1.0× 107 1.7k
Haiyan Xu China 21 531 1.1× 157 0.7× 68 0.4× 182 1.4× 93 0.8× 105 1.3k
Mohammad Abu Zaid United States 22 541 1.1× 241 1.1× 121 0.6× 128 1.0× 135 1.2× 59 1.7k
Haihua Huang China 20 664 1.4× 174 0.8× 139 0.7× 194 1.5× 99 0.9× 61 1.4k
Hülya Yılmaz Türkiye 24 489 1.0× 137 0.6× 124 0.6× 134 1.0× 97 0.9× 134 1.8k
Yogendra Singh India 23 332 0.7× 266 1.2× 83 0.4× 191 1.5× 136 1.2× 123 1.3k
Liang Zheng China 22 519 1.1× 323 1.4× 84 0.4× 239 1.9× 130 1.2× 65 1.6k

Countries citing papers authored by Rong Ding

Since Specialization
Citations

This map shows the geographic impact of Rong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Ding more than expected).

Fields of papers citing papers by Rong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Ding. The network helps show where Rong Ding may publish in the future.

Co-authorship network of co-authors of Rong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Ding. A scholar is included among the top collaborators of Rong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Ding. Rong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shumin, Nailin Yang, Zixian Yang, et al.. (2025). Nanomaterials intervene in cell senescence to reinforce cancer therapy. Coordination Chemistry Reviews. 545. 217012–217012. 5 indexed citations
2.
Ding, Rong, Yuming Jia, Kaijian Lei, et al.. (2025). Synergistic strategies in photodynamic combination therapy for cancer: mechanisms, nanotechnology, and clinical translation. Frontiers in Oncology. 15. 1607259–1607259. 2 indexed citations
3.
Zhang, Jing, et al.. (2024). Role of miRNA‑122 in cancer (Review). International Journal of Oncology. 65(3). 5 indexed citations
4.
Ding, Rong, Jinlin Huang, Xiaochen Shi, et al.. (2024). FNDC1 is a myokine that promotes myogenesis and muscle regeneration. The EMBO Journal. 44(1). 30–53. 6 indexed citations
6.
Wu, Yifan, Xiaoyu Wang, Changkai Shan, et al.. (2023). Comprehensive Profiling of Amine-Containing Metabolite Isomers with Chiral Phosphorus Reagents. Analytical Chemistry. 95(46). 16830–16839. 6 indexed citations
7.
Tian, Wenjing, Mi Zhou, Xiangzhong Liu, et al.. (2023). Apocarotenoids from Equisetum debile Roxb. ex Vaucher regulate the lipid metabolism via the activation of the AMPK/ACC/SREBP-1c signaling pathway. Bioorganic Chemistry. 138. 106639–106639. 7 indexed citations
8.
Deng, Ze, Hongyan Wang, Zhenxue Jiang, et al.. (2023). Interpretation Method for Lost Gas in Deep Coalbed and Its Application. Processes. 11(1). 200–200. 3 indexed citations
10.
Chen, Qilin, Huimin Jiang, Rong Ding, et al.. (2023). Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome. Frontiers in Immunology. 14. 1231937–1231937. 7 indexed citations
11.
Zhang, Xuan, Xinyi Cai, Yongchun Zhou, et al.. (2023). The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. Frontiers in Bioscience-Landmark. 28(11). 301–301. 4 indexed citations
12.
Cao, Ting, Guanghui Wang, Xin Jiang, et al.. (2022). Synthesis and Anti-Hepatoma Activities of U12 Derivatives Arresting G0/G1 Phase and Inducing Apoptosis by PI3K/AKT/mTOR Pathway. Pharmaceuticals. 15(1). 107–107. 5 indexed citations
13.
Ding, Rong, et al.. (2022). Identification of candidate targets and mechanisms involved in miRNA regulation in multiple myeloma. World Journal of Surgical Oncology. 20(1). 23–23. 4 indexed citations
14.
Zhang, Xuan, Tao Wu, Guoyu Li, et al.. (2022). Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI⁃H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study. Frontiers in Immunology. 13. 913483–913483. 33 indexed citations
15.
Wang, Qianqian, Tianyu Qu, Lingxiang Wu, et al.. (2021). High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Frontiers in Oncology. 11. 644575–644575. 16 indexed citations
17.
Ζhou, Mi, Xiangzhong Liu, Junjie Chen, et al.. (2020). Cytotoxic polyprenylated phloroglucinol derivatives from Hypericum elodeoides Choisy modulating the transactivation of RXRα. Bioorganic Chemistry. 107. 104578–104578. 13 indexed citations
18.
Li, Lingchang, Haiyan Wang, Guoli Wei, et al.. (2019). FuFangChangTai Decoction Activates Macrophages via Inducing Autophagy. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 6 indexed citations
19.
Yang, Xi, Yong Zhang, Chen Zhang, et al.. (2019). Thyroid function reference ranges during pregnancy in a large Chinese population and comparison with current guidelines. Chinese Medical Journal. 132(5). 505–511. 19 indexed citations
20.
Lin, Ting, Guanghui Wang, Wenjun Shan, et al.. (2014). Myrotheciumones: Bicyclic cytotoxic lactones isolated from an endophytic fungus of Ajuga decumbens. Bioorganic & Medicinal Chemistry Letters. 24(11). 2504–2507. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026